Igor Orsha

Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.

ChemDiv, Inc. operates as a discovery and development contract research organization. It specializes in early and clinical development of anti-infectives and antivirals, oncologics, CNS, cardiometabolics, and anti-inflammatory therapies. The firm?s services include synthetic chemistry, structural biology and structure-based drug discovery, molecular modeling, medicinal chemistry, scale-up, biochemical and cellular assay development, analytical/bioanalytical platforms, ADME/tox, DMPK, and multiple in vivo efficacy/tox models. The company was founded by Alexander Ivachtchenko in 1991 and is headquartered in San Diego, CA.

Avineuro Pharmaceuticals, Inc. discovers and develops novel small molecules for unmet medical needs in neurology and psychiatry. The company was founded by Alexandre V. Ivachtchenko in August 2008 and is headquartered in Hallandale Beach, FL.

Torrey Pines Investment, Inc (Torrey Pines Investment) is a venture capital firm is founded in 2002 by Nikolay Savchuk.The firm is headquartered San Diego, California.

Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA.

Viriom Ltd. operates as a biotech company which develops novel therapies for life threatening infections such as HIV and HBV. The company was founded in 2009 and is headquartered in Khimki, Russia.

ChemRar High-Tech Center provides investment services to biotech start-ups and research and development companies. It develops and commercializes medicines with therapeutic potential for Russia and ultimately the global market. The company was founded by Alexander Vasilievich Ivaschenko in 1990 and is headquartered in Khimki, Russia.

SatRx LLC provides pharmaceutical and pre-clinical development services. The private company is based in Moscow, Russian Federation. The Russian company was founded in 2010 by Yuliya Aleksandrovna Baybikova. The CEO is Oleg Igorevich Astafurov.

Chromis Therapeutics, Inc. focuses on the development of curative treatments for chronic HBV infection, based on its advanced proprietary drug design and discovery platform. Its CHR101 has a potential to eradicate HBV and to efficiently cure chronically infected HBV patients, as compared to drugs currently on the market. The company was founded by Vadim Bichko and is headquartered in San Diego, CA.

Alla Chem LLC is a pharmaceutical company that develops pharmaceutical products. The private company is based in Hallandale Beach, FL and was founded in 2004.

Teal Ventures Management LLC (Teal Ventures) is a venture capital firm founded by Nikolay Savchuk, Ron Demuth, and Eddie Rodriguez in 2018. The firm Headquartered in San Diego, California.

Viriom, Inc. is a biotechnology company based in San Diego, CA. The company focuses on developing innovative therapies for infectious diseases, including HIV and COVID-19. Viriom's mission is to improve the lives of patients by providing effective and accessible treatments. Iain David Dukes has been the CEO of the company since 2019, leading the team in their efforts to advance the development of their pipeline and bring new therapies to market.

Lomond Therapeutics, Inc. provides healthcare services. The CEO of the American company is Nikolay Savchuk.

Eil Therapeutics, Inc. offers therapeutic services. The CEO of the American company is Nikolay Savchuk.

Ness Therapeutics, Inc. provides oncology therapeutics. The CEO of the American company is Nikolay Savchuk.

Bala Therapeutics, Inc. is an oncology healthcare company. The company is based in San Diego, CA. The CEO of the company is Nikolay Savchuk.

Trawsfynydd Therapeutics, Inc. engages in discovering and developing antiviral medicines. The company is located in the US.